Acro Biomedical Co Ltd (ACBM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ACBM Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Acro Biomedical Co Ltd manages its resources, obligations, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Security Deposit0.00
Cash & Short-term Investments0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.00
Total Current Assets0.00
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets0.00
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.06
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.00
Total Current Liabilities0.43
Total Long-term Debt0.00
Due To Related Party Current0.38
Total Liabilities0.43
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock32.32
Retained Earnings / Accumulated Deficit-32.80
Other Equity0.00
Common Stockholder's Equity-0.43
Total Stockholder's Equity-0.43
Liabilities & Stockholder's Equity0.00
4 historic quarters locked

Sign in to unlock the full Acro Biomedical Co Ltd balance sheet history.

About Acro Biomedical Co Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: acbm_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001640334-26-001345

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.